Abstract
Full text links
Read article at publisher's site: https://doi.org/10.1016/j.cmet.2006.02.004
Read article for free, from open access legal sources, via Unpaywall:
http://www.cell.com/article/S1550413106000647/pdf
References
Articles referenced by this article (39)
Cannabinoid receptor antagonists and obesity.
Curr Opin Investig Drugs, (4):389-394 2004
MED: 15134279
Bonini, J.A., Borowsky, B.E., Adham, N., Boyle, N., and Thompson, T.O. (2002). Methods of identifying compounds that bind to SNORF25 receptors. U.S. Patent 6,468,756.
Evidence for a new G protein-coupled cannabinoid receptor in mouse brain.
Mol Pharmacol, (1):155-163 2001
MED: 11408610
The orphan G protein-coupled receptor GPR40 is activated by medium and long chain fatty acids.
J Biol Chem, (13):11303-11311 2002
MED: 12496284
Selective A1-adenosine receptor antagonists identified using yeast Saccharomyces cerevisiae functional assays.
Bioorg Med Chem Lett, (16):2413-2418 1999
MED: 10476879
Endogenous cannabinoid system as a modulator of food intake.
Int J Obes Relat Metab Disord, (3):289-301 2003
MED: 12629555
Isolation and structure of a brain constituent that binds to the cannabinoid receptor.
Science, (5090):1946-1949 1992
MED: 1470919
Seven evolutionarily conserved human rhodopsin G protein-coupled receptors lacking close relatives.
FEBS Lett, (3):381-388 2003
MED: 14623098
Oleylethanolamide regulates feeding and body weight through activation of the nuclear receptor PPAR-alpha.
Nature, (6953):90-93 2003
MED: 12955147
Fyfe, M., Gardner, L., King-Underwood, J., Procter, M., Rasamison, C., Schofield, K., and Thomas, G. (2005). Heterocyclic derivatives as GPCR receptor agonists. International Patent no. WO 2005/061489.
Show 10 more references (10 of 39)
Citations & impact
Impact metrics
Citations of article over time
Alternative metrics
Smart citations by scite.ai
Explore citation contexts and check if this article has been
supported or disputed.
https://scite.ai/reports/10.1016/j.cmet.2006.02.004
Article citations
Profile of uterine flush lipid mediators in cows with subclinical endometritis: pilot study.
J Vet Med Sci, 86(5):518-523, 25 Mar 2024
Cited by: 0 articles | PMID: 38522898 | PMCID: PMC11144532
Aerobic Exercise and Endocannabinoids: A Narrative Review of Stress Regulation and Brain Reward Systems.
Cureus, 16(3):e55468, 04 Mar 2024
Cited by: 0 articles | PMID: 38440201 | PMCID: PMC10910469
Review Free full text in Europe PMC
Orphan G protein-coupled receptors: the ongoing search for a home.
Front Pharmacol, 15:1349097, 29 Feb 2024
Cited by: 1 article | PMID: 38495099 | PMCID: PMC10941346
Review Free full text in Europe PMC
Physiological Appetite Regulation and Bariatric Surgery.
J Clin Med, 13(5):1347, 27 Feb 2024
Cited by: 0 articles | PMID: 38546831 | PMCID: PMC10932430
Review Free full text in Europe PMC
Interactions Between the Ubiquitin-Proteasome System, Nrf2, and the Cannabinoidome as Protective Strategies to Combat Neurodegeneration: Review on Experimental Evidence.
Neurotox Res, 42(2):18, 23 Feb 2024
Cited by: 1 article | PMID: 38393521 | PMCID: PMC10891226
Review Free full text in Europe PMC
Go to all (364) article citations
Other citations
Data
Similar Articles
To arrive at the top five similar articles we use a word-weighted algorithm to compare words from the Title and Abstract of each citation.
GPR119 is required for physiological regulation of glucagon-like peptide-1 secretion but not for metabolic homeostasis.
J Endocrinol, 201(2):219-230, 12 Mar 2009
Cited by: 90 articles | PMID: 19282326
Oleoylethanolamide, an endogenous PPAR-alpha agonist, lowers body weight and hyperlipidemia in obese rats.
Neuropharmacology, 48(8):1147-1153, 21 Apr 2005
Cited by: 165 articles | PMID: 15910890
Analysis of gene expression pattern reveals potential targets of dietary oleoylethanolamide in reducing body fat gain in C3H mice.
J Nutr Biochem, 21(10):922-928, 01 Dec 2009
Cited by: 18 articles | PMID: 19954948
GPR119 as a fat sensor.
Trends Pharmacol Sci, 33(7):374-381, 02 May 2012
Cited by: 97 articles | PMID: 22560300
Review
Oleoylethanolamide: A novel pharmaceutical agent in the management of obesity-an updated review.
J Cell Physiol, 234(6):7893-7902, 07 Dec 2018
Cited by: 16 articles | PMID: 30537148
Review